Review Article

Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice

Table 4

Leukocyte and lymphocytes count changes.

AEIncidence in individual studiesIncidence in all studies

Leukopenia and lymphopenia6.9%1.03%
Lymphocyte count decreased0.3%; 1.24%; 3.8%; 2.1%; 2.3%1.21%
Lymphopenia6.5%1.23%
White blood cell count decreased8.3%0.3%

Incidence in all studies was calculated by dividing the number of reports by the total population enrolled in the reviewed studies for safety outcomes.